The many challenges faced by the pharmaceutical industry throughout the supply chain, including fraud and counterfeit medicines, have led to international serialisation requirements in the U.S and Europe. With this in mind, CDMOs have a lot to consider with the new track and trace regulations.

While selecting the right serialisation solution provider is important, the key is to understand the customer and market requirements.

Staffan Widengren, our Director – Corporate Projects and Serialisation Programme Manager, discusses with Contract Pharma the three main potential hurdles and what you should expect from a CDMO partner.

Read the full 'The challenge of serialisation' article here

Contract Pharma, Sept 8, 2016